BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2010
View Archived Issues
PET/CT tracer anti-3-[18F]-FACBC effectively detects recurrent prostate cancer
Read More
Integrin alpha-V/beta-6 shows potential as biomarker for pancreatic cancer
Read More
Dexrazoxane is cardioprotective in rat model of myocardial infarction
Read More
Solvay discloses new potassium channel blockers
Read More
GlaxoSmithKline presents new AMPA receptor agonists
Read More
Centocor Ortho Biotech and Medivir claim new NS5B polymerase inhibitors
Read More
TopoTarget presents novel Nampt inhibitors
Read More
Novel P2X3 and P2X2/3 receptor antagonists claimed by Roche
Read More
TAK-701 shows promise in nonhematologic tumors
Read More
TXA-127 obtains FDA orphan drug status to enhance stem cell engraftment
Read More
Futura Medical and GSK join to develop TPR-100 for topical pain relief
Read More
Acotiamide meets primary endpoints in phase III trial in functional dyspepsia
Read More
FDA grants orphan drug status to Octreolin for oral treatment of acromegaly
Read More
AMAG and Takeda begin global registrational program of ferumoxytol
Read More
TZP-102 improves diabetic gastroparesis-related symptoms in phase II trial
Read More
Posaconazole for Chagas' disease enters phase II trial in South America
Read More
Vitae receives milestone payment as 11-beta-HSD1 inhibitor advances to phase I
Read More
EMA issues encouraging scientific advice on phase III perifosine trial in colorectal cancer
Read More
Tolerx begins confirmatory phase III trial of otelixizumab in type 1 diabetes
Read More
Pluristem to design phase IIb trials of PLX-PAD in CLI and claudication
Read More
Cubist meets objectives in phase II CXA-101 urinary tract infection study
Read More
Alnylam obtains approval to initiate phase I ALN-TTR01 study in amyloidosis
Read More
Alimera submits Iluvien NDA to FDA for diabetic macular edema
Read More
Immunovaccine and Oncothyreon to jointly develop cancer vaccine
Read More
Single-molecule digital ELISA shows potential in diagnosing prostate cancer
Read More